• Dr Jake Keeperman (MD, FACEP, FAEMS ) We Need Vascular Access Now – Intraosseous Access (2MB)

• Joy Blacka (RN,BN,MCP, VA-BC) US Guided PICC Insertion Workshop – Auckland (4.5MB)

• Jim Lacy (RN, BSN, VA-BC): Find Your Rhythm: What is the Optimal Tip Position for CVCs? (1MB)
• Arrow/Teleflex: Ultrasound Sound Assessment for Pneumothorax - Sliding Lung (0.7MB)

• Joy Blacka: Technological Innovations in VA (2MB)
• Arrow/Teleflex: Ultrasound Sound Assessment for Pneumothorax - Sliding Lung (0.7MB)

• Nancy Moureau: Technology Innovations (7MB)
• Chopra et al (2015) M.A.G.I.C. Guidelines (1MB)

• ARROW VA-AGB Science (MP4) (21MB)

• Joy Blacka: Brisbane IV Forum (900KB)
• Dr Cathryn Murphy: CLABSI - Is Zero Possible? (5.2MB)

• Marguerita Cirillo, Joy Blacka: Melbourne IV Forum (900KB)
• Catherine Pedrotti & Anna Kalliou: Royal Melbourne - Nurse Led PICC Clinic (1.4MB)
• Tanya Clark: Infusion Therapy PICC Service - Gold Coast University Hospital (2.7MB)

• Joy Blacka: Sydney IV Forum (900KB)
• Dr Evan Alexandrou: Towards Best Practice - Nurse Led CVC Placement (3MB)
• Dr Evan Alexandrou: OMG Presentation AVA 2015 (1.7MB)

• Prof Fiona Coyer: IAD Definition and Causes (1.3MB)
• Jill Campbell: IAD and Pressure Injury (1MB)
• Prof Fiona Coyer: IAD Assessment and Categories (2.3MB)
• Jill Campbell: IAD Prevention and Management (1.9MB)

• Joy Blacka: Safe Power Injection of Contrast Through Central Venous Catheters (1MB)

• The Sliding Lung Technique

• Arrow History (3MB)
• Professor Mary-Louise McClaws: CLABSI: Is ZERO Achievable? (2MB)

• Optimising Outcomes with PICCs (1.1MB)

• Open Course

• Open Course

• Open Course

• Open Course

• Presentation One: Teleflex Medical Australia Trauma Products (613K)
• Presentation Two: Hemorrhage Control Strategies Trauma - Dr Dennis Filips (5.2MB)

Tracey Patrick - Gold Coast Hospital “Advancing Your Vascular Access Team” Infusion Therapy PICC Services Gold Coast Hospital

Helen Hayes - Townsville Hospital “The Townsville Hospital Nurse Led PICC Journey

• Reducing Risk in Vascular Access - Amy Bardin (5.5MB)

• Reducing Risk in Vascular Access - Amy Bardin (1.8MB)

• Introduction: Joy Blacka (367KB)
• The Clinical Interface: Research & Vascular Access, AVATAR. Prof Claire Rickard (3MB)
• OMG Participant Information Form (190KB)

The ARROW^® AGB+ Central Venous Catheter is treated with chlorhexidine (CHX) throughout the internal fluid path and external catheter body surface to help prevent microbial colonisation and central-line associated bloodstream infections (CLABSI). Chlorhexidine is an ideal broad-spectrum antimicrobial4,5. Recent Australian clinical and economic research highlights the high incidence, substantial avoidable costs and preventability of CLABSI among intensive care unit patients.1-3 Extensive global use of CHX impregnated central venous catheters since the early 1990s has demonstrated their clinical and economic impact in CLABSI prevention.

1. McLaws ML, Burrell AR. Zero risk for central line-associated bloodstream infection: are we there yet? Crit Care Med. Feb 2012;40(2):388-393.
2. Burrell AR, McLaws ML, Murgo M, Calabria E, Pantle AC, Herkes R. Aseptic insertion of central venous lines to reduce bacteraemia. Med J Aust. Jun 6 2011;194(11):583-587.
3. Halton KA, Cook DA, Whitby M, Paterson DL, Graves N. Cost effectiveness of antimicrobial catheters in the intensive care unit: addressing uncertainty in the decision. Crit Care. 2009;13(2):R35.
4. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. May 2011;39(4 Suppl 1):S1-34.
5. Australian and New Zealand Intensive Care Society. ANZICS Central Line Insertion Maintenance Guidelines April 2012. In: ANZICS Safety and Quality Committee, ed. Melbourne 2012.

• “Chlorhexidine: Is it time to defend or de-friend” - Dr Cathryn Murphy (2.9MB)
• Details on the “OMG” Point Prevalence Study on Peripheral Cannula - Evan Alexandrou (900KB)

• Reducing Risk in Vascular Access - Joy Blacka, Amy Bardin (2.5MB)